Semi-Annual Consolidated Statement Of Income

OncoTherapy Science, Inc. - Filing #7329199

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
610,388,000 JPY
-270,000 JPY
610,118,000 JPY
698,000 JPY
609,690,000 JPY
1,125,769,000 JPY
9,372,000 JPY
1,135,142,000 JPY
-238,000 JPY
1,134,903,000 JPY
Cost of sales
787,836,000 JPY
1,093,218,000 JPY
Ordinary profit (loss)
-873,356,000 JPY
-1,136,373,000 JPY
-1,086,234,000 JPY
-1,133,099,000 JPY
Extraordinary income
269,528,000 JPY
5,225,000 JPY
38,186,000 JPY
38,231,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
56,500,000 JPY
56,500,000 JPY
50,680,000 JPY
52,680,000 JPY
Taxes and dues
4,000,000 JPY
4,350,000 JPY
143,979,000 JPY
144,125,000 JPY
Selling, general and administrative expenses
230,430,000 JPY
265,030,000 JPY
396,501,000 JPY
431,637,000 JPY
Extraordinary losses
402,744,000 JPY
154,564,000 JPY
68,146,000 JPY
21,553,000 JPY
Profit (loss) before income taxes
-1,006,572,000 JPY
-1,285,713,000 JPY
-1,116,193,000 JPY
-1,116,420,000 JPY
Operating profit (loss)
-910,192,000 JPY
-210,607,000 JPY
-889,202,000 JPY
-1,120,800,000 JPY
-674,559,000 JPY
-235,633,000 JPY
-1,086,031,000 JPY
-34,385,000 JPY
-690,746,000 JPY
-725,131,000 JPY
-381,283,000 JPY
-1,106,415,000 JPY
Income taxes - current
1,210,000 JPY
2,425,000 JPY
1,321,000 JPY
2,561,000 JPY
Non-operating income
Interest income
11,002,000 JPY
11,555,000 JPY
Non-operating income
30,742,000 JPY
26,000 JPY
26,958,000 JPY
576,000 JPY
Non-operating expenses
Interest expenses
218,000 JPY
JPY
Non-operating expenses
14,896,000 JPY
15,599,000 JPY
27,161,000 JPY
27,260,000 JPY
Income taxes - deferred
JPY
JPY
-338,000 JPY
-338,000 JPY
Income taxes
1,210,000 JPY
2,425,000 JPY
983,000 JPY
2,223,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
JPY
431,000 JPY
476,000 JPY
Profit (loss)
-1,007,782,000 JPY
-1,007,782,000 JPY
-1,007,782,000 JPY
-1,288,138,000 JPY
-1,007,782,000 JPY
-1,117,177,000 JPY
-1,117,177,000 JPY
-1,117,177,000 JPY
-1,117,177,000 JPY
-1,118,644,000 JPY
Extraordinary losses
Impairment losses
JPY
JPY
154,564,000 JPY
JPY
154,564,000 JPY
19,901,000 JPY
19,411,000 JPY
1,652,000 JPY
490,000 JPY
21,553,000 JPY
Profit (loss) attributable to owners of parent
-1,288,138,000 JPY
-1,288,138,000 JPY
-1,288,138,000 JPY
-1,118,644,000 JPY
-1,118,644,000 JPY
-1,118,644,000 JPY
Comprehensive income
-1,288,138,000 JPY
-1,118,644,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,288,138,000 JPY
-1,118,644,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.